Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS- CoV-2 vaccine candidates in the Syrian hamster model

The availability of a safe and effective vaccine would be the eventual measure to deal with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) threat. Here, we have assessed the immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidates BBV152A, BBV152B, and BBV152...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohandas, Sreelekshmy, Yadav, Pragya D., Shete-Aich, Anita, Abraham, Priya, Vadrevu, Krishna Mohan, Sapkal, Gajanan, Mote, Chandrashekhar, Nyayanit, Dimpal, Gupta, Nivedita, Srinivas, Vellimedu Kannappa, Kadam, Manoj, Kumar, Abhimanyu, Majumdar, Triparna, Jain, Rajlaxmi, Deshpande, Gururaj, Patil, Savita, Sarkale, Prasad, Patil, Deepak, Ella, Raches, Prasad, Sai D., Sharma, Sharda, Ella, Krishna M., Panda, Samiran, Bhargava, Balram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829205/
https://www.ncbi.nlm.nih.gov/pubmed/33521604
http://dx.doi.org/10.1016/j.isci.2021.102054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829205/
https://www.ncbi.nlm.nih.gov/pubmed/33521604
http://dx.doi.org/10.1016/j.isci.2021.102054

Ejemplares similares